| Name: | Bortezomib Impurity 4 |
| Catalogue No. | VE007395 |
| CAS No. | 862894-96-0 |
| Molecular Formula | C19H22N4O3 |
| Molecular Weight | 354.41 g/mol |
| Status | In-Stock |
| IUPAC Name | (S)-N-(1-(3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide |
| Description | Bortezomib Impurity 4 (CAS No: 862894-96-0) or (S)-N-(1-(3-methylbutanamido)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide is associate impurity of Bortezomib. Bortezomib is employed to treat people with multiple myeloma (a type of cancer of the bone marrow). ortezomib is during a category of medicines known as antineoplastic agents. |
| References | “Sci-Hub | Development of the Proteasome Inhibitor VelcadeTM (Bortezomib) | 10.1081/CNV-120030218.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1081/CNV-120030218. |
